Cardiovascular Diseases (enzymology) < Cardiovascular Diseases (epidemiology) < Cardiovascular Diseases (etiology)

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by Cardiovascular Diseases (epidemiology)

Number of relevant bibliographic references: 35.

Ident.	Authors (with country if any)	Title
000005 (2020)	Iva Golemi Minga [États-Unis] ; Lolita Golemi [États-Unis] ; Alfonso Tafur [États-Unis] ; Amit Pursnani [États-Unis]	The Novel Coronavirus Disease (COVID-19) and Its Impact on Cardiovascular Disease.
000007 (2020)	Awadhesh Kumar Singh [Inde] ; Ritesh Gupta [Inde] ; Anoop Misra [Inde]	Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers.
000017 (2020)	Meryem Aktoz ; Hakan Altay ; Emre Aslanger ; Enver Atalar ; Vedat Aytekin ; Ahmet Oytun Baykan ; Cem Barç N ; Nezihi Bar ; Asiye Ayça Boyac ; Yüksel Çavu O Lu ; Ahmet Çelik ; Göksel Çinier ; Muzaffer De Ertekin ; Önder Ergönül ; Mehmet Ertürk ; M Kemal Erol ; Bülent Görenek ; Mustafa Ozan Gürsoy ; Burak Hünük ; Gökhan Kahveci ; Can Yücel Karabay ; Ilg N Karaca ; Meral Kay Kç O Lu ; Muhammed Keskin ; Teoman K L Ç ; Cevat K Rma ; Umut Kocaba ; Serdar Küçüko Lu ; Bülent Mutlu ; Sanem Nalbantgil ; Ertu Rul Okuyan ; Kaan Okyay ; Deniz Kaptan Zen ; Sami Özgül ; Ebru Özpelit ; Bahar Pirat ; Sena Sert ; Ümit Ya Ar Sinan ; Yusuf Ziya Ener ; Ersan Tatl ; Ahmet Lker Tekke In ; Eralp Tutar ; Dilek Ural ; Özlem Y Ld R Mtürk	[Consensus Report from Turkish Society of Cardiology: COVID-19 and Cardiovascular Diseases. What cardiologists should know. (25th March 2020)].
000030 (2020)	Grzegorz Sławi Ski ; Ewa Lewicka	What should a cardiologist know about coronavirus disease 2019?
000036 (2020)	Ohad Oren ; Eric H. Yang ; Ty J. Gluckman ; Erin D. Michos ; Roger S. Blumenthal ; Bernard J. Gersh	Use of Chloroquine and Hydroxychloroquine in COVID-19 and Cardiovascular Implications: Understanding Safety Discrepancies to Improve Interpretation and Design of Clinical Trials.
000059 (2020)	Ishan Asokan [États-Unis] ; Soniya V. Rabadia [États-Unis] ; Eric H. Yang [États-Unis]	The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population.
000065 (2020)	Brian Xiangzhi Wang [Royaume-Uni]	Susceptibility and prognosis of COVID-19 patients with cardiovascular disease.
000067 (2020)	Tiago Peçanha [Brésil] ; Karla Fabiana Goessler [Brésil] ; Hamilton Roschel [Brésil] ; Bruno Gualano [Brésil]	Social isolation during the COVID-19 pandemic can increase physical inactivity and the global burden of cardiovascular disease.
000117 (2020)	Eamon Y. Duffy [États-Unis] ; Miguel Cainzos-Achirica [États-Unis] ; Erin D. Michos [États-Unis]	Primary and Secondary Prevention of Cardiovascular Disease in the Era of the Coronavirus Pandemic.
000126 (2020)		Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.
000131 (2020)	Edward Percy [États-Unis] ; Jessica G Y. Luc [Canada] ; Dominique Vervoort [États-Unis] ; Sameer Hirji [États-Unis] ; Marc Ruel [Canada] ; Thais Coutinho [Canada]	Post-Discharge Cardiac Care in the Era of Coronavirus 2019: How Should We Prepare?
000132 (2020)	Mary L. Adams ; David L. Katz ; Joseph Grandpre	Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States.
000133 (2020)	Giuseppe Lippi [Italie] ; Brandon M. Henry [États-Unis] ; Fabian Sanchis-Gomar [Espagne, États-Unis]	Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19).
000135 (2020)	Tommaso Gori [Allemagne] ; Jos Lelieveld [Allemagne] ; Thomas Münzel [Allemagne]	Perspective: cardiovascular disease and the Covid-19 pandemic.
000143 (2020)	Hao Cheng [République populaire de Chine] ; Yan Wang [République populaire de Chine] ; Gui-Qiang Wang [République populaire de Chine]	Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
000146 (2020)	Fabien Huet [France] ; Cyril Prieur [France] ; Guillaume Schurtz [France] ; Edouard Gerbaud [France] ; Stéphane Manzo-Silberman [France] ; Gerald Vanzetto [France] ; Meyer Elbaz [France] ; Victoria Tea [France] ; Grégoire Mercier [France] ; Benoît Lattuca [France] ; Claire Duflos [France] ; François Roubille [France]	One train may hide another: Acute cardiovascular diseases could be neglected because of the COVID-19 pandemic.
000177 (2020)	Antonio Ceriello [Italie] ; Eberhard Standl [Allemagne] ; Doina Catrinoiu [Roumanie] ; Baruch Itzhak [Israël] ; Nebojsa M. Lalic [Serbie] ; Dario Rahelic [Croatie] ; Oliver Schnell [Allemagne] ; Jan Škrha [République tchèque] ; Paul Valensi	Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
000233 (2020)	Ajay K. Gupta ; Hani Jneid ; Daniel Addison ; Hossein Ardehali ; Amelia K. Boehme ; Sanket Borgaonkar ; Romain Boulestreau ; Kevin Clerkin ; Nicolas Delarche ; Holli A. Devon ; Isabella M. Grumbach ; Jose Gutierrez ; Daniel A. Jones ; Vikas Kapil ; Carmela Maniero ; Amgad Mentias ; Pamela S. Miller ; Sher May Ng ; Jai D. Parekh ; Reynaldo H. Sanchez ; Konrad Teodor Sawicki ; Anneline S J M. Te Riele ; Carol Ann Remme ; Barry London	Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors.
000296 (2020)	Mingyue Li [République populaire de Chine] ; Yalan Dong [République populaire de Chine] ; Haijun Wang [République populaire de Chine] ; Weina Guo [République populaire de Chine] ; Haifeng Zhou [République populaire de Chine] ; Zili Zhang [République populaire de Chine] ; Chunxia Tian [République populaire de Chine] ; Keye Du [République populaire de Chine] ; Rui Zhu [République populaire de Chine] ; Li Wang [République populaire de Chine] ; Lei Zhao [République populaire de Chine] ; Heng Fan [République populaire de Chine] ; Shanshan Luo [République populaire de Chine] ; Desheng Hu [République populaire de Chine]	Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19.
000305 (2020)	Andrea Barison [Italie] ; Alberto Aimo [Italie] ; Vincenzo Castiglione [Italie] ; Chiara Arzilli [Italie] ; Josep Lup N [Espagne] ; Pau Codina [Espagne] ; Evelyn Santiago-Vacas [Espagne] ; Germán Cediel [Espagne] ; Michele Emdin [Italie] ; Antoni Bayes-Genis [Espagne]	Cardiovascular disease and COVID-19: les liaisons dangereuses.
000312 (2020)	Usaid K. Allahwala [Australie] ; A Robert Denniss [Australie] ; Sarah Zaman [Australie] ; Ravinay Bhindi [Australie]	Cardiovascular Disease in the Post-COVID-19 Era - the Impending Tsunami?
000313 (2020)	Chia Siang Kow [Malaisie] ; Syed Tabish Razi Zaidi [Royaume-Uni] ; Syed Shahzad Hasan [Royaume-Uni]	Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19.
000314 (2020)	Alexander C. Razavi ; Tanika N. Kelly ; Jiang He ; Camilo Fernandez ; Paul K. Whelton ; Marie Krousel-Wood ; Lydia A. Bazzano	Cardiovascular Disease Prevention and Implications of Coronavirus Disease 2019: An Evolving Case Study in the Crescent City.
000320 (2020)	Ghazal Aghagoli [États-Unis] ; Benjamin Gallo Marin [États-Unis] ; Luke B. Soliman [États-Unis] ; Frank W. Sellke [États-Unis]	Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review.
000325 (2020)	Yaling Han [République populaire de Chine] ; Hesong Zeng [République populaire de Chine] ; Hong Jiang [République populaire de Chine] ; Yuejin Yang [République populaire de Chine] ; Zuyi Yuan [République populaire de Chine] ; Xiang Cheng [République populaire de Chine] ; Zhicheng Jing [République populaire de Chine] ; Bin Liu [République populaire de Chine] ; Jiyan Chen [République populaire de Chine] ; Shaoping Nie [République populaire de Chine] ; Jianhua Zhu [République populaire de Chine] ; Fei Li [République populaire de Chine] ; Changsheng Ma [République populaire de Chine]	CSC Expert Consensus on Principles of Clinical Management of Patients With Severe Emergent Cardiovascular Diseases During the COVID-19 Epidemic.
000329 (2020)	Antonio Ceriello [Italie] ; Oliver Schnell [Allemagne]	COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.
000330 (2020)	J. Saban-Ruiz [Oman] ; D. Ly-Pen	COVID-19: A Personalized Cardiometabolic Approach for Reducing Complications and Costs. The Role of Aging beyond Topics.
000334 (2020)	Marijana Tadic [Serbie] ; Cesare Cuspidi [Italie] ; Giuseppe Mancia [Italie] ; Raffaella Dell'Oro [Italie] ; Guido Grassi [Italie]	COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?
000369 (2020)	Faten Yahia ; Lilia Zakhama ; Ahmed Ben Abdelaziz	COVID-19 and Cardiovascular diseases. Scoping review study.
000373 (2020)	Marijke Linschoten [Pays-Bas] ; Folkert W. Asselbergs [Pays-Bas]	CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic.
000374 (2020)	Katalin Gémes [Suède] ; Mats Talb Ck [Suède] ; Karin Modig [Suède] ; Anders Ahlbom [Suède] ; Anita Berglund [Suède] ; Maria Feychting [Suède] ; Anthony A. Matthews [Suède]	Burden and prevalence of prognostic factors for severe COVID-19 in Sweden.
000377 (2020)	Inayat Hussain Khan [Royaume-Uni] ; Syeda Anum Zahra [Royaume-Uni] ; Sevim Zaim [Royaume-Uni] ; Amer Harky [Royaume-Uni]	At the heart of COVID-19.
000380 (2020)	Gaurav Aggarwal ; Isaac Cheruiyot ; Saurabh Aggarwal ; Johnny Wong ; Giuseppe Lippi ; Carl J. Lavie ; Brandon M. Henry ; Fabian Sanchis-Gomar	Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis.
000392 (2020)	Mengmeng Zhao [République populaire de Chine] ; Menglong Wang [République populaire de Chine] ; Jishou Zhang [République populaire de Chine] ; Jing Ye [République populaire de Chine] ; Yao Xu [République populaire de Chine] ; Zhen Wang [République populaire de Chine] ; Di Ye [République populaire de Chine] ; Jianfang Liu [République populaire de Chine] ; Jun Wan [République populaire de Chine]	Advances in the relationship between coronavirus infection and cardiovascular diseases.
000402 (2020)	Gang Li [République populaire de Chine] ; Rui Hu [République populaire de Chine] ; Xuefang Gu [République populaire de Chine]	A close-up on COVID-19 and cardiovascular diseases.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Cardiovascular Diseases (epidemiology)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Cardiovascular Diseases (epidemiology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CardioCovidV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Cardiovascular Diseases (epidemiology)
}}

---

This area was generated with Dilib version V0.6.35. Data generation: Tue Aug 4 15:08:30 2020. Site generation: Wed Jan 27 11:23:02 2021